Who
Mark Hopman
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Beta Bionics.
In numbers
- Trades disclosed
- 55
- Buys
- 0
- Sells
- 19
- Bought
- $0
- Sold
- $5.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Jan 2025
- Last trade
- 14 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Oct 2026filed 16 Oct 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $13K775 at $17.35 | filing |
| 1 Oct 2026filed 5 Oct 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $7,015370 at $18.96 | filing |
| 16 Sep 2026filed 17 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $620K30,779 at $20.13 | filing |
| 16 Sep 2026filed 17 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $620K30,779 at $20.13 | filing |
| 14 Sep 2026filed 15 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $12K775 at $15.52 | filing |
| 14 Sep 2026filed 15 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $12K775 at $15.52 | filing |
| 9 Sep 2026filed 18 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $665K35,994 at $18.46 | filing |
| 9 Sep 2026filed 18 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $664K35,994 at $18.46 | filing |
| 9 Sep 2026filed 10 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $681K36,870 at $18.46 | filing |
| 9 Sep 2026filed 10 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $681K36,870 at $18.46 | filing |
| 2 Sep 2026filed 3 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $102K5,327 at $19.11 | filing |
| 2 Sep 2026filed 3 Sep 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $102K5,327 at $19.11 | filing |
| 24 Jun 2026filed 25 Jun 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $19K1,258 at $15.01 | filing |
| 24 Jun 2026filed 25 Jun 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $19K1,258 at $15.01 | filing |
| 4 Jun 2026filed 5 Jun 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $3,385275 at $12.31 | filing |
| 4 Jun 2026filed 5 Jun 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $3,385275 at $12.31 | filing |
| 2 Jun 2026filed 3 Jun 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $67K5,329 at $12.61 | filing |
| 2 Jun 2026filed 3 Jun 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $67K5,329 at $12.61 | filing |
| 4 Mar 2026filed 5 Mar 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $4,084353 at $11.57 | filing |
| 4 Mar 2026filed 5 Mar 2026 | BBNX Beta BionicsMedical Devices | SEC FORM 4 Sold | $4,084353 at $11.57 | filing |
News
Mark Hopman Sells 36,870 Shares of Beta Bionics (NASDAQ:BBNX) Stocktickerreport.com · 10 Sep 2026BBNX DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Beta Bionics, Inc. Investors to ...BBNX · gazettextra.com · 24 Oct 2026Investor Notification: Beta Bionics ($BBNX) Investors Are Reminded to Contact BFA Law About the Ongoing Securities Fraud Class Action to Recover LossesBBNX · thesudburystar.com · 24 Oct 2026BBNX DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important November 3 Deadline in Securities Class Action - BBNXBBNX · wallstreet-online.de · 22 Oct 2026
1 headline in the last 90 days name Mark Hopman; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.